Streptococcus pyogenes Rosenbach (ATCC® BAA-947)

Strain Designations: MGAS 5005  /  Type Strain: no  /  Biosafety Level: 2

Strain Designations MGAS 5005
Application
Emerging infectious disease research
Isolation
Human clinical specimen, cerebrospinal fluid, Toronto, Ontario, Canada, October 5, 1996
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Antigenic Properties Serotype M1
Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Genome Sequenced Strain

Streptococcus pyogenes MGAS5005, complete genome.

Type Strain no
Antigenic Properties Serotype M1
Comments
Genome sequenced strain
Name of Depositor JM Musser, D Low
Special Collection ATCC
Isolation
Human clinical specimen, cerebrospinal fluid, Toronto, Ontario, Canada, October 5, 1996
Year of Origin 1996
References

Virtaneva K, et al. Group A Streptococcus gene expression in humans and cynomolgus macaques with acute pharyngitis. Infect. Immun. 71: 2199-2207, 2003. PubMed: 12654842

James M Musser, personal communication

Cross References

Nucleotide (GenBank) : CP000017 Streptococcus pyogenes MGAS5005, complete genome.